Oxford Immunotec Global PLC Ordinary Shares
OXFD
OXFD was delisted on the 5th of March, 2021.
83 hedge funds and large institutions have $390M invested in Oxford Immunotec Global PLC Ordinary Shares in 2018 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 35 increasing their positions, 23 reducing their positions, and 9 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
67% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 9
52% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 23
42% more capital invested
Capital invested by funds: $275M → $390M (+$114M)
8% more funds holding
Funds holding: 77 → 83 (+6)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$5.06M |
| 2 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$4M |
| 3 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$3.23M |
| 4 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$2.45M |
| 5 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$1.98M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Axa
Paris,
France
|
-$6.19M |
| 2 |
NLVP
New Leaf Venture Partners
New York
|
-$4.02M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$3.96M |
| 4 |
DM
Deerfield Management
New York
|
-$3.2M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$2.22M |
OXFD Hedge Fund Activity: Q3 2018 in Review
83 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Oxford Immunotec Global PLC Ordinary Shares (OXFD) for Q3 2018, worth a combined $390M — up 42% from $275M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new OXFD positions and 9 closed out — a net gain of 6 holders — while 35 added to existing stakes and 23 trimmed.
The largest buyer was First Light Asset Management, adding an estimated $5.06M. The largest seller was Axa, exiting entirely with an estimated $6.19M sold.
- 83 institutional investors held Oxford Immunotec Global PLC Ordinary Shares (OXFD) as of Q3 2018, up from 77 in Q2 2018.
- Funds reported $390M of Oxford Immunotec Global PLC Ordinary Shares stock for Q3 2018, up 42% quarter-over-quarter.
- 15 funds opened new Oxford Immunotec Global PLC Ordinary Shares positions in Q3 2018 and 9 closed out, a net change of +6 holders.
- The largest Oxford Immunotec Global PLC Ordinary Shares buyer in Q3 2018 was First Light Asset Management, an estimated $5.06M added.
- The largest Oxford Immunotec Global PLC Ordinary Shares seller in Q3 2018 was Axa, an estimated $6.19M sold.
Based on aggregated 13F filings for Q3 2018.